Bacterial outer membrane vesicles OMV-LL for delivery of neoantigen mRNA to induce anti-HCC therapy
This study highlights OMV-LL as an innovative mRNA delivery approach to DCs for CTLs activation and demonstrates their potential in CTLs-based therapy for HCC.
Authors
- Shengzhe Lin (ORCID: https://orcid.org/0009-0000-2520-8957)
- Fang Liu (ORCID: https://orcid.org/0000-0003-1121-3004)
- Shuping Chen (ORCID: https://orcid.org/0000-0002-3460-3788)
- Chenlu Zhu (ORCID: https://orcid.org/0009-0009-6238-1324)
- Yunbin Ye (ORCID: https://orcid.org/0000-0002-5208-1872)
- Suxin Wu
- Jinghua Cheng (ORCID: https://orcid.org/0009-0006-6964-1211)
Institutions
- Fujian Medical University (CN)
- Fujian Provincial Cancer Hospital (CN)
- Union Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-08-29
- DOI
- https://doi.org/10.3389/fimmu.2025.1633345
- Citations
- 1
- Primary Topic
- Bacterial Infections and Vaccines
- Type
- article
- Field-Weighted Citation Impact
- 1.18
Funders
- Natural Science Foundation of Fujian Province